Undervalued stock screener
What the screener does, and does not do
This undervalued stock screener ranks US-listed companies by research priority, based on valuation, quality, growth, risk and technical data. It flags stocks that look cheap against an estimate of their intrinsic value, but places no orders and makes no buy or sell recommendations.
Some call it an undervalued stock scanner, yet it has no real-time prices, ignores chart patterns and sends no trading alerts.
US stocks trading below estimated intrinsic value (24h delayed)
The table above is the public preview: up to eight top-scored companies. Valuation carries the most weight in the score, so top-ranked companies tend to trade below the screener’s base-case estimate of their value. The preview shows only a research priority, from “High research priority” (score of 75 or more) down to “Limited data” (below 45).
Undervalued stock screener criteria and weights
Each company gets a research score from 0 to 100. Missing values show as N/A, never as zero, and a confidence score out of 100 reflects how complete the inputs are. The methodology page lists the data sources.
| Family (weight) | What the screener measures | Why it matters |
|---|---|---|
| Valuation (40%) | Upside to the base-case fair value estimate, minus penalties for a P/E above 22 or a price-to-book above 6 | The discount is the margin of safety. |
| Quality (25%) | ROE, ROA, net and operating margins | Separates sound businesses from weak ones. |
| Growth (15%) | One-year EPS and revenue growth | A low multiple on a shrinking business is rarely a bargain. |
| Risk (15%) | Beta, plus a penalty when the estimate is more than 10% below the price | Volatile or already expensive stocks leave less room for error. |
| Technical (5%) | Price against the 50-day and 200-day moving averages | Context only. |
The current model does not score free cash flow or debt, so check them in the filings. A low P/E with falling earnings is often a value trap.
Universe and update cadence
US-listed stocks only, from the Nasdaq Trader symbol directory, with fundamentals from SEC EDGAR filings and data providers. ETFs, ADRs, SPACs, warrants, thinly traded stocks and companies below a market-cap floor are excluded by default. Data is refreshed in batches and every row is dated.
Free stock screener for US stocks: preview vs member workspace
Free, no account: the delayed preview above, and nothing more.
Members (yearly plan or lifetime access, see pricing): the full ranked table with price, fair value range (bear, base and bull cases), upside, score, confidence and sub-scores; advanced filters (set a minimum upside to list stocks below their estimated fair value); and company views with upcoming catalysts when available.
How to use the screener in a research workflow
- Shortlist 5 to 10 names by sector, market cap, risk and score.
- Rebuild the estimate with the intrinsic value (DCF) calculator or the Benjamin Graham formula calculator.
- Read the 10-K and 10-Q on SEC EDGAR: debt, free cash flow, one-off items, share count.
- Check upcoming events in the stock catalyst calendar.
- Write down the thesis and what would invalidate it, following our guide on how to find undervalued stocks and the examples in our stock research reports.
Frequently asked questions
Is the undervalued stock screener free?
Only the delayed preview on this page: up to eight rows, data at least 24 hours old, no account needed.
What criteria make a stock undervalued here?
Mainly a price below the base-case fair value estimate. Quality, growth and risk also count, so a cheap but fragile company does not automatically rank high.
Which markets does the screener cover?
US-listed stocks only (Nasdaq, NYSE and other US exchanges): no European stocks, ETFs, ADRs or SPACs.
How is fair value estimated?
With positive earnings, the base case is EPS times a sector P/E adjusted for ROE, net margin and beta, blended with the analyst price target when one exists (65% model, 35% target). Bear and bull cases sit 20% below and above. It is not a DCF.
How often is the data updated?
In batches on the server, never by a page visit. Each row shows its date, and the public preview lags by at least 24 hours.
Is a high research priority a buy recommendation?
No. It flags a company worth deeper research, not personalized advice. See the full disclaimer.
Scores, fair value ranges and research priorities are educational estimates based on assumptions, not recommendations to buy or sell.
Open the full screener
The full ranked table with fair value ranges, sub-scores and filters, plus research reports and the catalyst calendar.
See the plansRead the methodology